- Home
- CNTB vs IHD Comparison
CNTB vs IHD Comparison
Compare CNTB & IHD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CNTB
- IHD
- Stock Information
- Founded
- CNTB 2012
- IHD 2011
- Country
- CNTB United States
- IHD United States
- Employees
- CNTB N/A
- IHD N/A
- Industry
- CNTB Biotechnology: Pharmaceutical Preparations
- IHD Investment Managers
- Sector
- CNTB Health Care
- IHD Finance
- Exchange
- CNTB Nasdaq
- IHD Nasdaq
- Market Cap
- CNTB 94.2M
- IHD 108.0M
- IPO Year
- CNTB 2021
- IHD N/A
- Fundamental
- Price
- CNTB $1.59
- IHD $6.46
- Analyst Decision
- CNTB Strong Buy
- IHD
- Analyst Count
- CNTB 2
- IHD 0
- Target Price
- CNTB $7.50
- IHD N/A
- AVG Volume (30 Days)
- CNTB 79.5K
- IHD 27.7K
- Earning Date
- CNTB 11-30-2025
- IHD 01-01-0001
- Dividend Yield
- CNTB N/A
- IHD 10.32%
- EPS Growth
- CNTB N/A
- IHD N/A
- EPS
- CNTB N/A
- IHD N/A
- Revenue
- CNTB $1,965,000.00
- IHD N/A
- Revenue This Year
- CNTB N/A
- IHD N/A
- Revenue Next Year
- CNTB $453,067.90
- IHD N/A
- P/E Ratio
- CNTB N/A
- IHD N/A
- Revenue Growth
- CNTB N/A
- IHD N/A
- 52 Week Low
- CNTB $1.23
- IHD $4.49
- 52 Week High
- CNTB $2.20
- IHD $5.47
- Technical
- Relative Strength Index (RSI)
- CNTB 45.14
- IHD 64.70
- Support Level
- CNTB $1.50
- IHD $6.29
- Resistance Level
- CNTB $1.72
- IHD $6.49
- Average True Range (ATR)
- CNTB 0.13
- IHD 0.11
- MACD
- CNTB -0.02
- IHD 0.01
- Stochastic Oscillator
- CNTB 18.00
- IHD 92.68
About CNTB Connect Biopharma Holdings Limited
Connect Biopharma Holdings Ltd is a clinical-stage company focused on the discovery and development of next-generation immune modulators for the treatment of serious autoimmune diseases and inflammation. It has leveraged its expertise in the biology of T cell modulation to build a portfolio of drug candidates consisting of small molecules and antibodies targeting critical pathways of inflammation. Its pipeline includes CBP-201, CBP-307 and CBP-174.
About IHD Voya Emerging Markets High Income Dividend Equity Fund
Voya Emerging Markets High Dividend Equity Fund is a diversified closed-end management investment company. Its primary investment objective is to provide total return through a combination of current income, capital gains, and capital appreciation. The company seeks to achieve its investment objectives by investing principally in a portfolio of equity securities, and issuers in emerging market countries. The Fund will also normally seek to secure gains and enhance the stability of returns over a market cycle by writing (selling) call options on selected exchange-traded funds (ETFs) and/or international, regional, or country indices of equity securities, and/or on equity securities.